These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 34656769)
1. Cost Implications of Using Carbetocin Injection to Prevent Postpartum Hemorrhage in a Canadian Urban Hospital. Barrett J; Ko S; Jeffery W J Obstet Gynaecol Can; 2022 Mar; 44(3):272-278. PubMed ID: 34656769 [TBL] [Abstract][Full Text] [Related]
2. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis. Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India. Cook JR; Saxena K; Taylor C; Jacobs JL BMC Health Serv Res; 2023 Mar; 23(1):267. PubMed ID: 36932411 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia. Gil-Rojas Y; Lasalvia P; Hernández F; Castañeda-Cardona C; Rosselli D Rev Bras Ginecol Obstet; 2018 May; 40(5):242-250. PubMed ID: 29913541 [TBL] [Abstract][Full Text] [Related]
5. Clinical and financial evaluation of carbetocin as postpartum haemorrhage prophylaxis at caesarean section: A retrospective cohort study. Wohling J; Edge N; Pena-Leal D; Wang R; Mol BW; Dekker G Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):501-507. PubMed ID: 30411314 [TBL] [Abstract][Full Text] [Related]
6. Current research on carbetocin and implications for prevention of postpartum haemorrhage. Theunissen FJ; Chinery L; Pujar YV Reprod Health; 2018 Jun; 15(Suppl 1):94. PubMed ID: 29945640 [TBL] [Abstract][Full Text] [Related]
7. Carbetocin for preventing postpartum haemorrhage. Su LL; Chong YS; Samuel M Cochrane Database Syst Rev; 2012 Feb; (2):CD005457. PubMed ID: 22336812 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of carbetocin versus oxytocin for the prevention of postpartum hemorrhage following vaginal birth in the United Kingdom. Matthijsse S; Andersson FL; Gargano M; Yip Sonderegger YL J Med Econ; 2022; 25(1):129-137. PubMed ID: 35007465 [TBL] [Abstract][Full Text] [Related]
9. Cost of hospital care of women with postpartum haemorrhage in India, Kenya, Nigeria and Uganda: a financial case for improved prevention. Theunissen F; Cleps I; Goudar S; Qureshi Z; Owa OO; Mugerwa K; Piaggio G; Gülmezoglu AM; Nakalembe M; Byamugisha J; Osoti A; Mandeep S; Poriot T; Gwako G; Vernekar S; Widmer M Reprod Health; 2021 Jan; 18(1):18. PubMed ID: 33482858 [TBL] [Abstract][Full Text] [Related]
10. A prospective cohort study evaluating the cost-effectiveness of carbetocin for prevention of postpartum haemorrhage in caesarean sections. Luni Y; Borakati A; Matah A; Skeats K; Eedarapalli P J Obstet Gynaecol; 2017 Jul; 37(5):601-604. PubMed ID: 28317421 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of carbetocin for prevention of postpartum hemorrhage in a low-burden high-resource city of China. You JHS; Leung TY PLoS One; 2022; 17(12):e0279130. PubMed ID: 36520799 [TBL] [Abstract][Full Text] [Related]
12. Carbetocin versus oxytocin for prevention of post-partum haemorrhage at caesarean section in the United Kingdom: An economic impact analysis. van der Nelson HA; Draycott T; Siassakos D; Yau CWH; Hatswell AJ Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():286-291. PubMed ID: 28088109 [TBL] [Abstract][Full Text] [Related]
13. Room temperature stable carbetocin for the prevention of postpartum haemorrhage during the third stage of labour in women delivering vaginally: study protocol for a randomized controlled trial. Widmer M; Piaggio G; Abdel-Aleem H; Carroli G; Chong YS; Coomarasamy A; Fawole B; Goudar S; Hofmeyr GJ; Lumbiganon P; Mugerwa K; Nguyen TM; Qureshi Z; Souza JP; Gülmezoglu AM Trials; 2016 Mar; 17(1):143. PubMed ID: 26988231 [TBL] [Abstract][Full Text] [Related]
14. Oxytocin agonists for preventing postpartum haemorrhage. Su LL; Chong YS; Samuel M Cochrane Database Syst Rev; 2007 Jul; (3):CD005457. PubMed ID: 17636798 [TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomic study comparing carbetocin with oxytocin for the prevention of hemorrhage following cesarean delivery in Lima, Peru. Caceda SI; Ramos RR; Saborido CM J Comp Eff Res; 2018 Jan; 7(1):49-55. PubMed ID: 29264934 [TBL] [Abstract][Full Text] [Related]
16. Carbetocin versus oxytocin for the prevention of postpartum hemorrhage: A meta-analysis of randomized controlled trials in cesarean deliveries. Voon HY; Suharjono HN; Shafie AA; Bujang MA Taiwan J Obstet Gynecol; 2018 Jun; 57(3):332-339. PubMed ID: 29880160 [TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness analysis of carbetocin during cesarean section in a high volume maternity unit. Voon HY; Shafie AA; Bujang MA; Suharjono HN J Obstet Gynaecol Res; 2018 Jan; 44(1):109-116. PubMed ID: 29027315 [TBL] [Abstract][Full Text] [Related]
18. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. Leduc D; Senikas V; Lalonde AB; J Obstet Gynaecol Can; 2009 Oct; 31(10):980-993. PubMed ID: 19941729 [TBL] [Abstract][Full Text] [Related]
19. A systematic review of the cost-effectiveness of uterotonic agents for the prevention of postpartum hemorrhage. Lawrie TA; Rogozińska E; Sobiesuo P; Vogel JP; Ternent L; Oladapo OT Int J Gynaecol Obstet; 2019 Jul; 146(1):56-64. PubMed ID: 31049950 [TBL] [Abstract][Full Text] [Related]
20. Carbetocin versus oxytocin for prevention of postpartum hemorrhage after vaginal delivery in high risk women. Maged AM; Hassan AM; Shehata NA J Matern Fetal Neonatal Med; 2016; 29(4):532-6. PubMed ID: 25731657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]